Dr. Wolfe is an Associate Professor of Medicine in the Division of Infectious Disease at Duke. Dr. Wolfe is also the Chief Medical Director for Duke’s Emerging Pathogens Unit, which focuses on preparedness in the event of emerging biothreats, especially at the moment, the 2019 novel Coronavirus.  He also serves as one of the core Transplant Infectious Disease faculty.   Locally, he lectures in the Community Preparedness and Disaster Management class at the School of Public Health at UNC-Chapel Hill, as well as at Duke University Medical School. Nationally, his expertise in the fields of transplantation and emerging infections in the immunocompromised has been recognized with appointment as the Chair of the national HHS Disease Transmission Advisory Committee from 2016-2018.

Cameron now serves as an At-Large member of the Board of Directors of the Organ Procurement and Transplant Network.  Under his leadership, the OPTN and national organ procurement sganizations fostered the re-writing of the PHS Increased Risk Guidelines for organ donors, and re-wrote policy accounting for emerging pathogens, including Zika, ebola and MERs-CoV.    Dr. Wolfe maintains an active HIV practice and continues his clinical research, with multiple influenza and respiratory viral studies ongoing at Duke.